Exemple: Heart Attack

Essais cliniques parrainés par The LAM Foundation

5 résultats au total

NCT04388371

Inscription sur invitation

Glutamine PET Imaging in LAM

Conditions: Lymphangioleiomyomatosis (LAM)
NCT02061397

Terminé

Safety of Simvastatin in LAM and TSC

Conditions: Lymphangioleiomyomatosis; Tuberous Sclerosis Complex
NCT00457808

Terminé

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Conditions: Tuberous Sclerosis; Lymphangioleiomyomatosis
NCT03150914

Recrutement

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

Conditions: LAM; Lymphangioleiomyomatosis
NCT02432560

Actif, ne recrute pas

Safety and Durability of Sirolimus for Treatment of LAM

Conditions: Lymphangioleiomyomatosis